SCHEMBL4523894

SCHEMBL4523894

CCOC(=O)c1[nH]c2ccc(Oc3c(Cl)cc(C(=O)N(C)C(=O)O)cc3Cl)cc2c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
HPGD P15428 5/20 0.58
KDM4E B2RXH2 5/20 0.58
MAPT P10636 5/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
LMNA P02545 4/20 0.45
HSD17B10 Q99714 3/20 0.45
CYP1A2 P05177 2/20 0.44
XBP1 P17861 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.43
GALR3 O60755 1/20 0.42
HCRTR1 O43613 1/20 0.42
GAA P10253 4/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3990468 0.92 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL4523898 0.84 MAPT (0.55) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL4518559 0.81 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL9737589 0.78 ALDH1A1 (0.73) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL3990474 0.76 KDM4E (0.47) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL3993248 0.75 ALDH1A1 (1.00) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL4077176 0.73 ALDH1A1 (0.69) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL6596157 0.73 ALDH1A1 (0.76) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL3987539 0.73 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EMAPTNPC1
SCHEMBL6983821 0.72 HCRTR1 (0.76) ALDH1A1HPGDKDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA ALDH1A1 1439/4885HPGD 2564/4885KDM4E 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.